{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:33:10Z","timestamp":1791919990087,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ejmech.2022.114460","type":"journal-article","created":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T01:51:43Z","timestamp":1652493103000},"page":"114460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["New peptidomimetic rhodesain inhibitors with improved selectivity towards human cathepsins"],"prefix":"10.1016","volume":"238","author":[{"given":"Sascha","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6404-676X","authenticated-orcid":false,"given":"Natalie","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Grathwol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute A.","family":"Hellmich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Willmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Sotriffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Schirmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2022.114460_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/0471140864.ps2102s21","article-title":"Papain-like cysteine proteases","volume":"21","author":"Br\u00f6mme","year":"2000","journal-title":"Curr. Protoc. Protein Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114460_bib2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1515\/bmc-2012-0054","article-title":"Papain-like peptidases: structure, function, and evolution","volume":"4","author":"Novinec","year":"2013","journal-title":"Biomol. Concepts"},{"key":"10.1016\/j.ejmech.2022.114460_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100565","article-title":"Structure, interdomain dynamics and PH-dependent autoactivation of pro-rhodesain, the main lysosomal cysteine protease from african trypanosomes","author":"Joh\u00e9","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2022.114460_bib4","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.drudis.2015.05.005","article-title":"Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies","volume":"20","author":"Bauer","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"7","key":"10.1016\/j.ejmech.2022.114460_bib5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1517\/17460441.2012.688744","article-title":"Drug discovery for a new generation of covalent drugs","volume":"7","author":"Kalgutkar","year":"2012","journal-title":"Expet Opin. Drug Discov."},{"issue":"35","key":"10.1016\/j.ejmech.2022.114460_bib6","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1002\/anie.201203341","article-title":"Reversible covalent inhibition of a protein target","volume":"51","author":"Lee","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2022.114460_bib7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejmech.2017.06.019","article-title":"Covalent inhibitors design and discovery","volume":"138","author":"de Cesco","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"27","key":"10.1016\/j.ejmech.2022.114460_bib8","doi-asserted-by":"crossref","first-page":"8332","DOI":"10.1021\/jacs.6b03052","article-title":"Quantum chemical-based protocol for the rational design of covalent inhibitors","volume":"138","author":"Schirmeister","year":"2016","journal-title":"J. Am. Chem. Soc."},{"issue":"13","key":"10.1016\/j.ejmech.2022.114460_bib9","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2174\/1568026618666180731161438","article-title":"Covalent inhibition in drug discovery: filling the void in literature","volume":"18","author":"Bjij","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"issue":"14","key":"10.1016\/j.ejmech.2022.114460_bib10","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1021\/jm301424d","article-title":"Inhibition of rhodesain as a novel therapeutic modality for human african Trypanosomiasis","volume":"56","author":"Ettari","year":"2013","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114460_bib11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ijpara.2012.03.009","article-title":"Trypanosoma brucei: chemical evidence that cathepsin L is essential for survival and a relevant drug target","volume":"42","author":"Steverding","year":"2012","journal-title":"Int. J. Parasitol."},{"issue":"10","key":"10.1016\/j.ejmech.2022.114460_bib12","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1172\/JCI27798.","article-title":"Blood-brain barrier traversal by african trypanosomes requires calcium signaling induced by parasite cysteine protease","volume":"116","author":"Nikolskaia","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114460_bib13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/expr.1998.4381","article-title":"Trypanosoma brucei: killing of bloodstream formsin vitroandin vivoby the cysteine proteinase inhibitor Z-phe-ala-CHN2","volume":"91","author":"Scory","year":"1999","journal-title":"Exp. Parasitol."},{"issue":"9683","key":"10.1016\/j.ejmech.2022.114460_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage african trypanosoma brucei gambiense Trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial","volume":"374","author":"Priotto","year":"2009","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ejmech.2022.114460_bib15","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.pt.2003.09.002","article-title":"Chemotherapy of human african Trypanosomiasis: current and future prospects","volume":"19","author":"Fairlamb","year":"2003","journal-title":"Trends Parasitol."},{"issue":"38","key":"10.1016\/j.ejmech.2022.114460_bib16","doi-asserted-by":"crossref","first-page":"25697","DOI":"10.1074\/jbc.M109.014340","article-title":"Vinyl sulfones as antiparasitic agents and a structural basis for drug design","volume":"284","author":"Kerr","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.ejmech.2022.114460_bib17","doi-asserted-by":"crossref","first-page":"12322","DOI":"10.1021\/acs.jmedchem.1c01002","article-title":"Fluorovinylsulfones and -sulfonates as potent covalent reversible inhibitors of the trypanosomal cysteine protease rhodesain: structure-activity relationship, inhibition mechanism, metabolism, and in vivo studies","volume":"64","author":"Jung","year":"2021","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2022.114460_bib18","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/cmdc.200500102","article-title":"Structure-based searching in large fragment spaces","volume":"1","author":"Degen","year":"2006","journal-title":"ChemMedChem"},{"issue":"10","key":"10.1016\/j.ejmech.2022.114460_bib19","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1002\/cmdc.200800178","article-title":"On the art of compiling and using \u201cdrug-like\u201d chemical fragment spaces","volume":"3","author":"Degen","year":"2008","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2022.114460_bib20","series-title":"LeadIT\/FlexX","year":"2012"},{"issue":"5","key":"10.1016\/j.ejmech.2022.114460_bib21","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1039\/b718304f","article-title":"Q. \u201cclick\u201d synthesis of small-molecule inhibitors targeting caspases","volume":"6","author":"Ng","year":"2008","journal-title":"Org. Biomol. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114460_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0166-6851(01)00368-1","article-title":"Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of trypanosoma brucei rhodesiense","volume":"118","author":"Caffrey","year":"2001","journal-title":"Mol. Biochem. Parasitol."},{"issue":"12","key":"10.1016\/j.ejmech.2022.114460_bib23","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1021\/acsmedchemlett.6b00276","article-title":"Dipeptidyl nitroalkenes as potent reversible inhibitors of cysteine proteases rhodesain and cruzain","volume":"7","author":"Latorre","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114460_bib24","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1021\/ci500681r","article-title":"DOCKTITE-A highly versatile step-by-step workflow for covalent docking and virtual screening in the molecular operating environment","volume":"55","author":"Scholz","year":"2015","journal-title":"J. Chem. Inf. Model."},{"issue":"10","key":"10.1016\/j.ejmech.2022.114460_bib25","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.bmcl.2006.02.026","article-title":"Aziridine-2,3-Dicarboxylate inhibitors targeting the major cysteine protease of trypanosoma brucei as lead trypanocidal agents","volume":"16","author":"Vicik","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"21","key":"10.1016\/j.ejmech.2022.114460_bib26","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1016\/j.bmc.2015.09.029","article-title":"Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation","volume":"23","author":"Ettari","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2022.114460_bib27","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.3390\/molecules25092064","article-title":"Naphthoquinones as covalent reversible inhibitors of cysteine proteases\u2014studies on inhibition mechanism and kinetics","volume":"25","author":"Klein","year":"2020","journal-title":"Molecules"},{"issue":"16","key":"10.1016\/j.ejmech.2022.114460_bib28","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.1021\/acs.jmedchem.7b00405","article-title":"Development of novel peptide-based Michael acceptors targeting rhodesain and falcipain-2 for the treatment of neglected tropical diseases (NTDs)","volume":"60","author":"Previti","year":"2017","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2022.114460_bib29","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/anie.201810470","article-title":"Inhibitor-induced dimerization of an essential oxidoreductase from african trypanosomes","volume":"58","author":"Wagner","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"issue":"12","key":"10.1016\/j.ejmech.2022.114460_bib30","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0968-0896(98)80022-9","article-title":"Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors","volume":"6","author":"Scheidt","year":"1998","journal-title":"Bioorg. Med. Chem."},{"issue":"17","key":"10.1016\/j.ejmech.2022.114460_bib31","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1055\/s-0034-1378867","article-title":"Chromatography-free and eco-friendly synthesis of aryl tosylates and mesylates","volume":"47","author":"Lei","year":"2015","journal-title":"Synthesis"},{"issue":"13","key":"10.1016\/j.ejmech.2022.114460_bib32","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1021\/ja111060q","article-title":"Rh2(II)-Catalyzed nitro-group migration reactions: selective synthesis of 3-nitroindoles from \u03b2-nitro styryl azides","volume":"133","author":"Stokes","year":"2011","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114460_bib33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/jo051980e","article-title":"Synthesis of the multisubstituted halogenated olefins via cross-coupling of dihaloalkenes with alkylzinc bromides","volume":"71","author":"Andrei","year":"2006","journal-title":"J. Org. Chem."},{"issue":"24","key":"10.1016\/j.ejmech.2022.114460_bib34","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1021\/acs.jmedchem.9b01697","article-title":"Proline-based allosteric inhibitors of zika and dengue virus NS2B\/NS3 proteases","volume":"62","author":"Millies","year":"2019","journal-title":"J. Med. Chem."},{"issue":"25","key":"10.1016\/j.ejmech.2022.114460_bib35","doi-asserted-by":"crossref","first-page":"6837","DOI":"10.1021\/acs.jpcb.1c01797","article-title":"Conformational dynamics of the dengue virus protease revealed by fluorescence correlation and single-molecule FRET studies","volume":"125","author":"G\u00f6tz","year":"2021","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2022.114460_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116392","article-title":"SAR of novel benzothiazoles targeting an allosteric pocket of DENV and ZIKV NS2B\/NS3 proteases","volume":"47","author":"Maus","year":"2021","journal-title":"Bioorg. Med. Chem."},{"issue":"23","key":"10.1016\/j.ejmech.2022.114460_bib37","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Yung-Chi","year":"1973","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114460_bib38","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1021\/bi00534a031","article-title":"Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier","volume":"21","author":"Tian","year":"1982","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2022.114460_bib39","series-title":"Molecular Operating Environment (MOE) | MOEsaic | PSILO","year":"2014"},{"key":"10.1016\/j.ejmech.2022.114460_bib40","unstructured":"Colibri BioSolveIT GmbH: St. Augustin, Germany 2010."},{"issue":"10","key":"10.1016\/j.ejmech.2022.114460_bib41","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1021\/ci200274q","article-title":"A knowledge-based scoring function for the assessment of protein-ligand complexes","volume":"51","author":"Neudert","year":"2011","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114460_bib42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0166-6851(96)02815-0","article-title":"Vectors for inducible expression of toxic gene products in bloodstream and procyclic trypanosoma brucei","volume":"85","author":"Biebinger","year":"1997","journal-title":"Mol. Biochem. Parasitol."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114460_bib43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0035-9203(62)90088-3","article-title":"Antigenic analysis in the trypanosoma brucei group, using the agglutination reaction","volume":"56","author":"Cunningham","year":"1962","journal-title":"Trans. R. Soc. Trop. Med. Hyg."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422003622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422003622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T14:11:14Z","timestamp":1728396674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422003622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":43,"alternative-id":["S0223523422003622"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114460","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New peptidomimetic rhodesain inhibitors with improved selectivity towards human cathepsins","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114460"}}